Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gilles Bleau is active.

Publication


Featured researches published by Gilles Bleau.


Fertility and Sterility | 1997

Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9)

Louise Lapensée; Yves Paquette; Gilles Bleau

OBJECTIVE To determine if the gene coding for human oviductin (the estrogen-dependent, oviduct-specific glycoprotein with an affinity for the zona pellucida) shows length polymorphism in the region of tandem repeats. To determine the frequencies of the length alleles in health and disease. DESIGN Descriptive fundamental and clinical studies. SETTING Fertility clinic and research center, university teaching hospital. PATIENT(S) Fertile women, women with a history of ectopic pregnancy or tubal disease, and women with stage I or II endometriosis. INTERVENTION(S) Blood samples were drawn for DNA analysis. MAIN OUTCOME MEASURE(S) Length and sequence of the region of tandem repeats. RESULT(S) Four different length alleles of the human oviductin gene were identified. Their relative frequencies in pathologic cases were not statistically significant compared with those found in normal fertile women. The human genome contains a single copy of the oviductin gene located on chromosome 1p13. CONCLUSION(S) The human oviductin gene codes for a glycoprotein that shares the characteristics of epithelial mucins. Because eight epithelial mucin genes have been identified so far, we therefore propose to name this gene MUC9. The biologic function of the protein is likely to include protection of the early embryo and of the fallopian tube itself.


Biological Trace Element Research | 1996

Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution.

Denis Vézina; François Mauffette; Kenneth D. Roberts; Gilles Bleau

In order to verify the hypothesis that selenium (Se) and vitamin E (Vit E) could improve male fertility, nine oligoasthenoteratozoospermic men were supplemented for a period of 6 mo with Se and Vit E. Compared to the baseline period (presupplementation) of 4 mo, statistically significant increases were observed for Se and Vit E levels, sperm motility, percent live, and percent normal spermatozoa. These improvements are likely to be “supplementation-dependent,” since all of the parameters returned to baseline values during the posttreatment period. None of the couples reported a pregnancy during the study. The HPLC analysis conducted on the serum of one of the patients showed the existence of at least six different Se-containing peaks, whose Se content was affected by supplementation. The mechanism(s) involved in these improvements of semen parameters is presently under investigation.


Biochimica et Biophysica Acta | 1974

Cholesterol sulfate. I. Occurrence and possible biological functions as an amphipathic lipid in the membrane of the human erythrocyte

Gilles Bleau; Frank H. Bodley; Jacques Longpré; Kenneth D. Roberts

Abstract Cholesterol sulfate is a normal constituent of human erythrocytes at a concentration which is approximately 2-fold higher than plasma cholesterol sulfate. In these cells, the major fraction of the cholesterol sulfate is firmly bound to the membrane. Cholesterol sulfate as well as certain analogs can project the red blood cell against hypotonic hemolysis. This effect is produced in vitro at physiological concentrations of the sterol sulfate and both the sulfate moiety as well as the side chain of the molecule are necessary for biological activity.


Fertility and Sterility | 1984

Semen selenium and human fertility

Gilles Bleau; Jacques Lemarbre; Guy Faucher; Kenneth D. Roberts

Selenium (Se) was measured in the semen of 125 men from couples consulting for infertility. A mean concentration of 71.3 +/- 29.7 ng/ml of semen was found, with a range of 7 to 230 ng/ml. More than 85% of the Se is in the seminal plasma. There was a significant positive correlation between sperm count and semen Se. Sperm motility was maximal at semen Se levels ranging between 50 and 69 ng/ml; above and below this range, motility was decreased and the incidence of asthenospermia was high. This result suggests an optimal range for semen Se. A follow-up of 4.5 to 5 years after the initial assay of Se revealed that low semen Se levels (less than or equal to 35 ng/ml) were associated with male infertility. A Se level between approximately 40 and 70 ng/ml was optimal for reproductive performance (high pregnancy rate and low abortion rate). Semen Se levels greater than or equal to 80 ng/ml were associated with a high abortion rate and signs of ovarian dysfunction in the partner (both partners usually have the same diet and environmental exposure). These results attest to the role of Se in human reproduction, a well-established fact in several animal species. The semen Se level appears to be a useful indicator of Se status versus reproductive function. Further studies are warranted concerning the general aspects of metabolism and mechanism of action of Se in infertile couples before any therapeutic modification of intake of this element can be contemplated.


Fertility and Sterility | 1988

Male infertility associated with round-headed acrosomeless spermatozoa*

Laurent Lalonde; Jean Langlais; Pierre Antaki; Kenneth D. Roberts; Gilles Bleau

The properties of spermatozoa with round head syndrome in four unrelated patients are reported. The findings were as follows: (1) Electron microscopy demonstrated that all spermatozoa lacked an acrosome and postacrosomal sheath. (2) Acrosin activity was only 1% to 6% of that found in sperm obtained from fertile donors. (3) Phospholipase A2 activity was not significantly different from that of spermatozoa from donors of unknown fertility. (4) Electrophoresis of whole sperm extracts revealed deficiencies in major protein bands. (5) The round-headed spermatozoa failed to bind or penetrate the vitellus in the egg penetration test. (6) The rates of chemically induced nuclear chromatin decondensation of round-headed spermatozoa suggest that the acrosome content is not involved in this process.


Steroids | 1976

Cholesteryl sulfate and sterol sulfatase in the human reproductive tract

Gaston Lalumière; Gilles Bleau; Kenneth D. Roberts

Cholesteryl sulfate is a component of human seminal plasma (avg. 445 mug%) and spermatozoa (15 mug/10 (9) cells) and represents more than 85% of the sterol sulfate fraction. This conjugate is avidly bound by spermatozoa when compared to other steroids or steroid sulfates. Autoradiographic localization of CS associated with the spermatozoa revealed a greater accumulation of the radioactivity in the acrosomal region in many, but not all, of those cells examined. Semen is not a site of metabolism of the sterol sulfate but the enzyme, sterol sulfatase, is present in the human female reproductive tract. This cleavage enzyme was detected in Graafian follicles and the activity in the endometrium was ten-fold that found in the Fallopian tube. These findings lead to the proposal that cholesteryl sulfate, an amphipathic molecule ideally suited for interaction with membrane components and implicated in erythrocyte membrane stabilization, may be involved in membrane modifications of the spermatozoa during the process of fertilization.


Steroids | 1980

Plasma estrone sulfate levels in postmenopausal women

Kenneth D. Roberts; J.G. Rochefort; Gilles Bleau

Estrone sulfate levels were measured in the plasma of 63 postmenopausal women. The assay method involved prior extraction of the free estrogens, enzyme hydrolysis of the estrone sulfate with sulfatase and radioimmunoassay of the estrone liberated. The plasma levels ranged from 37 to 320 pg/ml (expressed as free estrone) with a mean value of 178 +/- 79 pg/ml. As observed in premenopause, estrone sulfate is quantitatively the most important circulating estrogen in postmenopausal women.


Journal of Histochemistry and Cytochemistry | 1988

Immunoelectron microscopic localization of an oviductal antigen in hamster zona pellucida by use of a monoclonal antibody

Frederick W.K. Kan; Sylvie St-Jacques; Gilles Bleau

The zona pellucida is an extracellular matrix of glycoproteins which surrounds the mammalian oocyte and preimplantation embryo. We have recently developed monoclonal antibodies against oviductal zona pellucida of the golden hamster. We applied the post-embedding immunocytochemical method using a monoclonal antibody (IgGl,k) to determine the precise location of antigenic sites in the cumulus oophorus complex of the superovulated hamster. By applying the high-resolution protein A-gold technique, we demonstrated that the sites of immunoreactivity were exclusively in the zona pellucida encompassing the oocyte. Other structures within the oocyte and neighboring cumulus cells were not labeled by gold particles. Moreover, gold particles were evenly distributed throughout the entire thickness of the zona pellucida, indicating that this extracellular layer is at least in part made up of an antigen recognized by the monoclonal antibody that is uniformly distributed in the zona matrix.


Biochimica et Biophysica Acta | 1975

Red cell surface structure: Stabilization by cholesterol sulfate as evidenced by scanning electron microscopy

Gilles Bleau; Gaston Lalumière; Kenneth D. Roberts

Scanning electron microscopic studies demonstrate that the normal biconcave shape of the human erythrocyte is maintained in hypotonic saline when physiological levels (10 minus 5M) of cholesterol sulfate are added to the solutions. Cholesterol sulfate is a naturally occurring sterol conjugate in plasma and erythrocyte membranes and we propose that it may belong to that class of amphipathic molecules responsible for the maintenance of structure of the erythrocyte by interaction with membrane components.


Molecular and Cellular Endocrinology | 1981

Proliferation and differentiation of canine prostatic epithelial cells in culture

S. Chevalier; Gilles Bleau; Kenneth D. Roberts

When cultured in monolayers, non-secretory epithelial cells from canine prostates actively synthesize DNA, RNA and proteins; subsequently, mitotic figures and an increase in cell number are observed. During this culture period, cell size and acid phosphatase activity remain constant. As the culture proceeds, these cells mature into secretory cells as evidenced by a gradual shift in their density in Percoll gradients to the density of secretory cells and by an increase in the cellular content of acid phosphatase. During maturation, the size of the non-secretory cells increases and their morphology changes and becomes similar to that of the secretory cells. When a homogeneous population of secretory cells is cultured, DNA synthesis is minimal and few mitotic figures may be observed while cell number and cell density remain constant. Early in the culture period, their size increases and by 2 weeks their acid phosphatase activity is 2--3-fold higher than that of the non-secretory cells. Thus, upon culture, the non-secretory epithelial cells enter and proceed through the cell cycle with evidence of DNA synthesis and mitosis. Those cells leaving the cycle undergo maturation into secretory cells which further differentiate with the concomitant appearance of acid phosphatase activity. This model will be useful to study prostatic hyperplasia and hypertrophy and the control mechanisms involved in these phenomena.

Collaboration


Dive into the Gilles Bleau's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Chevalier

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G.M. Dupuy

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Jean Langlais

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Sergerie

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Y. Legault

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Yves Paquette

Université de Montréal

View shared research outputs
Researchain Logo
Decentralizing Knowledge